Gene therapy in inherited blood disorders: A spotlight on sickle cell disease and beta‑thalassaemia

  Inherited blood disorders are a group of conditions that alter the production, structure or function of blood cells, often requiring coordinated long-term management of patients. Haemoglobinopathies represent a subgroup of inherited blood disorders characterised by genetic changes in the haemoglobin, a key protein in the blood responsible for oxygen transport. Sickle cell disease (SCD) and beta-thalassaemia are two …

Enthusiasm, versatility and expertise pay off in Porterhouse’s scientific services team

We are delighted to congratulate Suzanne on her well-deserved promotion, and welcome her to the Porterhouse Medical Advisory Group.

Haematology developments from ASH 2018
Highlights in haematologic malignancy from ASH 2018

The ASH congress is the most comprehensive haematology event of the year, over 5000 abstracts covering new developments in malignant and non-malignant haematology were presented. Here we focus on two areas of personalised medicine from the oncology setting.